CN Patent

CN110790817A — 一种多肽类化合物、制剂、药物组合物及制备方法、应用

Assigned to Chengdu Noho Sheng Tai Biotechnology Co Ltd · Expires 2020-02-14 · 6y expired

What this patent protects

本发明公开了一种多肽类化合物、制剂、药物组合物及制备方法、应用，所述多肽类化合物的结构式如通式(I)： 该类多肽类化合物作为κ阿片样物质受体激动剂具有活性更好、副作用更小、成药性更好的优点。

USPTO Abstract

本发明公开了一种多肽类化合物、制剂、药物组合物及制备方法、应用，所述多肽类化合物的结构式如通式(I)： 该类多肽类化合物作为κ阿片样物质受体激动剂具有活性更好、副作用更小、成药性更好的优点。

Drugs covered by this patent

Patent Metadata

Patent number
CN110790817A
Jurisdiction
CN
Classification
—
Expires
2020-02-14
Drug substance claim
No
Drug product claim
No
Assignee
Chengdu Noho Sheng Tai Biotechnology Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.